Viewing Study NCT00276692


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-03-15 @ 11:39 AM
Study NCT ID: NCT00276692
Status: COMPLETED
Last Update Posted: 2013-06-26
First Post: 2006-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma
Sponsor: Children's Cancer and Leukaemia Group
Organization:

Organization Data

Organization:
Class: NIH
Study ID: CCLG-ET-2003-04
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators